Clinical Trial Update: Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing octanoate breath test to MRI for diagnosis of hepatocellular carcinoma (HCC) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Meridian Bioscience, Inc. | Conditions: Hepatocellular Carcinoma (HCC) | Phase 2 | Status: COMPLETED